UniProt ID | RNPS1_HUMAN | |
---|---|---|
UniProt AC | Q15287 | |
Protein Name | RNA-binding protein with serine-rich domain 1 | |
Gene Name | RNPS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 305 | |
Subcellular Localization | Nucleus. Nucleus speckle. Cytoplasm. Nucleocytoplasmic shuttling protein. Colocalizes with the core EJC, ALYREF/THOC4, NXF1 and UAP56 in the nucleus and nuclear speckles. | |
Protein Description | Part of pre- and post-splicing multiprotein mRNP complexes. Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP and PSAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Enhances the formation of the ATP-dependent A complex of the spliceosome. Involved in both constitutive splicing and, in association with SRP54 and TRA2B/SFRS10, in distinctive modulation of alternative splicing in a substrate-dependent manner. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Participates in mRNA 3'-end cleavage. Involved in UPF2-dependent nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Also mediates increase of mRNA abundance and translational efficiency. Binds spliced mRNA 20-25 nt upstream of exon-exon junctions.. | |
Protein Sequence | MDLSGVKKKSLLGVKENNKKSSTRAPSPTKRKDRSDEKSKDRSKDKGATKESSEKDRGRDKTRKRRSASSGSSSTRSRSSSTSSSGSSTSTGSSSGSSSSSASSRSGSSSTSRSSSSSSSSGSPSPSRRRHDNRRRSRSKSKPPKRDEKERKRRSPSPKPTKVHIGRLTRNVTKDHIMEIFSTYGKIKMIDMPVERMHPHLSKGYAYVEFENPDEAEKALKHMDGGQIDGQEITATAVLAPWPRPPPRRFSPPRRMLPPPPMWRRSPPRMRRRSRSPRRRSPVRRRSRSPGRRRHRSRSSSNSSR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MDLSGVKKKSL ----CCCCCCCCHHH | 36.96 | 22199227 | |
4 (in isoform 2) | Phosphorylation | - | 36.96 | 25849741 | |
4 (in isoform 3) | Phosphorylation | - | 36.96 | 25849741 | |
6 (in isoform 2) | Phosphorylation | - | 8.05 | 29514088 | |
6 (in isoform 3) | Phosphorylation | - | 8.05 | 29514088 | |
7 | 2-Hydroxyisobutyrylation | -MDLSGVKKKSLLGV -CCCCCCCCHHHCCC | 58.99 | - | |
7 | Acetylation | -MDLSGVKKKSLLGV -CCCCCCCCHHHCCC | 58.99 | 25953088 | |
7 | Sumoylation | -MDLSGVKKKSLLGV -CCCCCCCCHHHCCC | 58.99 | 28112733 | |
10 | Phosphorylation | LSGVKKKSLLGVKEN CCCCCCHHHCCCCCC | 37.39 | 26074081 | |
15 | Sumoylation | KKSLLGVKENNKKSS CHHHCCCCCCCCCCC | 53.58 | 28112733 | |
21 | Phosphorylation | VKENNKKSSTRAPSP CCCCCCCCCCCCCCC | 38.25 | 23403867 | |
22 | Phosphorylation | KENNKKSSTRAPSPT CCCCCCCCCCCCCCC | 30.69 | 23403867 | |
23 | Phosphorylation | ENNKKSSTRAPSPTK CCCCCCCCCCCCCCC | 37.63 | 30183078 | |
27 | Phosphorylation | KSSTRAPSPTKRKDR CCCCCCCCCCCCCCC | 44.19 | 30266825 | |
29 | Phosphorylation | STRAPSPTKRKDRSD CCCCCCCCCCCCCCC | 48.06 | 30266825 | |
35 | Phosphorylation | PTKRKDRSDEKSKDR CCCCCCCCCHHHCHH | 61.32 | 20068231 | |
39 | Phosphorylation | KDRSDEKSKDRSKDK CCCCCHHHCHHHHCC | 37.43 | - | |
40 | Methylation | DRSDEKSKDRSKDKG CCCCHHHCHHHHCCC | 69.13 | 116252731 | |
43 | Phosphorylation | DEKSKDRSKDKGATK CHHHCHHHHCCCCCH | 56.17 | 30576142 | |
49 | Phosphorylation | RSKDKGATKESSEKD HHHCCCCCHHHHHHH | 43.97 | 24144214 | |
52 | Phosphorylation | DKGATKESSEKDRGR CCCCCHHHHHHHHCC | 45.40 | 26657352 | |
53 | Phosphorylation | KGATKESSEKDRGRD CCCCHHHHHHHHCCC | 50.16 | 20068231 | |
67 | Phosphorylation | DKTRKRRSASSGSSS CCHHHHHHCCCCCCC | 36.21 | - | |
69 | Phosphorylation | TRKRRSASSGSSSTR HHHHHHCCCCCCCCC | 36.16 | 29052541 | |
70 | Phosphorylation | RKRRSASSGSSSTRS HHHHHCCCCCCCCCC | 42.27 | 29052541 | |
72 | Phosphorylation | RRSASSGSSSTRSRS HHHCCCCCCCCCCCC | 24.06 | 29052541 | |
73 | Phosphorylation | RSASSGSSSTRSRSS HHCCCCCCCCCCCCC | 38.97 | 29052541 | |
74 | Phosphorylation | SASSGSSSTRSRSSS HCCCCCCCCCCCCCC | 29.54 | 29052541 | |
77 | Phosphorylation | SGSSSTRSRSSSTSS CCCCCCCCCCCCCCC | 36.28 | - | |
78 | Methylation | GSSSTRSRSSSTSSS CCCCCCCCCCCCCCC | 36.95 | 115386567 | |
80 | Phosphorylation | SSTRSRSSSTSSSGS CCCCCCCCCCCCCCC | 36.20 | - | |
81 | Phosphorylation | STRSRSSSTSSSGSS CCCCCCCCCCCCCCC | 33.29 | - | |
82 | Phosphorylation | TRSRSSSTSSSGSST CCCCCCCCCCCCCCC | 34.28 | - | |
83 | Phosphorylation | RSRSSSTSSSGSSTS CCCCCCCCCCCCCCC | 25.18 | - | |
84 | Phosphorylation | SRSSSTSSSGSSTST CCCCCCCCCCCCCCC | 38.51 | 30576142 | |
85 | Phosphorylation | RSSSTSSSGSSTSTG CCCCCCCCCCCCCCC | 42.32 | - | |
87 | Phosphorylation | SSTSSSGSSTSTGSS CCCCCCCCCCCCCCC | 32.18 | - | |
88 | Phosphorylation | STSSSGSSTSTGSSS CCCCCCCCCCCCCCC | 29.87 | - | |
89 | Phosphorylation | TSSSGSSTSTGSSSG CCCCCCCCCCCCCCC | 31.82 | - | |
90 | Phosphorylation | SSSGSSTSTGSSSGS CCCCCCCCCCCCCCC | 32.49 | 30576142 | |
91 | Phosphorylation | SSGSSTSTGSSSGSS CCCCCCCCCCCCCCC | 40.97 | - | |
93 | Phosphorylation | GSSTSTGSSSGSSSS CCCCCCCCCCCCCCC | 22.78 | - | |
94 | Phosphorylation | SSTSTGSSSGSSSSS CCCCCCCCCCCCCCC | 39.81 | - | |
95 | Phosphorylation | STSTGSSSGSSSSSA CCCCCCCCCCCCCCC | 44.37 | - | |
97 | Phosphorylation | STGSSSGSSSSSASS CCCCCCCCCCCCCCC | 29.06 | - | |
98 | Phosphorylation | TGSSSGSSSSSASSR CCCCCCCCCCCCCCC | 37.45 | - | |
100 | Phosphorylation | SSSGSSSSSASSRSG CCCCCCCCCCCCCCC | 31.69 | - | |
101 | Phosphorylation | SSGSSSSSASSRSGS CCCCCCCCCCCCCCC | 33.83 | - | |
103 | Phosphorylation | GSSSSSASSRSGSSS CCCCCCCCCCCCCCC | 28.38 | - | |
104 | Phosphorylation | SSSSSASSRSGSSST CCCCCCCCCCCCCCC | 30.13 | - | |
106 | Phosphorylation | SSSASSRSGSSSTSR CCCCCCCCCCCCCCC | 45.00 | 30576142 | |
108 | Phosphorylation | SASSRSGSSSTSRSS CCCCCCCCCCCCCCC | 23.51 | - | |
109 | Phosphorylation | ASSRSGSSSTSRSSS CCCCCCCCCCCCCCC | 40.95 | 30576142 | |
112 | Phosphorylation | RSGSSSTSRSSSSSS CCCCCCCCCCCCCCC | 31.92 | 30576142 | |
114 | Phosphorylation | GSSSTSRSSSSSSSS CCCCCCCCCCCCCCC | 34.05 | 29262532 | |
115 | Phosphorylation | SSSTSRSSSSSSSSG CCCCCCCCCCCCCCC | 32.88 | 29262532 | |
116 | Phosphorylation | SSTSRSSSSSSSSGS CCCCCCCCCCCCCCC | 35.17 | 29262532 | |
117 | Phosphorylation | STSRSSSSSSSSGSP CCCCCCCCCCCCCCC | 35.87 | 29262532 | |
118 | Phosphorylation | TSRSSSSSSSSGSPS CCCCCCCCCCCCCCC | 35.87 | 29262532 | |
119 | Phosphorylation | SRSSSSSSSSGSPSP CCCCCCCCCCCCCCC | 30.39 | 29262532 | |
120 | Phosphorylation | RSSSSSSSSGSPSPS CCCCCCCCCCCCCCC | 40.44 | 27174698 | |
121 | Phosphorylation | SSSSSSSSGSPSPSR CCCCCCCCCCCCCCH | 45.28 | 27174698 | |
123 | Phosphorylation | SSSSSSGSPSPSRRR CCCCCCCCCCCCHHH | 24.93 | 25849741 | |
125 | Phosphorylation | SSSSGSPSPSRRRHD CCCCCCCCCCHHHHH | 36.89 | 21082442 | |
127 | Phosphorylation | SSGSPSPSRRRHDNR CCCCCCCCHHHHHCC | 42.64 | 30576142 | |
139 | Phosphorylation | DNRRRSRSKSKPPKR HCCHHHHCCCCCCCC | 42.39 | 26657352 | |
141 | Phosphorylation | RRRSRSKSKPPKRDE CHHHHCCCCCCCCCH | 52.20 | 26657352 | |
155 | Phosphorylation | EKERKRRSPSPKPTK HHHHHHCCCCCCCCE | 33.49 | 22167270 | |
157 | Phosphorylation | ERKRRSPSPKPTKVH HHHHCCCCCCCCEEE | 46.96 | 22167270 | |
161 | Phosphorylation | RSPSPKPTKVHIGRL CCCCCCCCEEEHHHH | 52.40 | 30266825 | |
166 (in isoform 3) | Ubiquitination | - | 12.03 | 21890473 | |
173 | Phosphorylation | GRLTRNVTKDHIMEI HHHCCCCCHHHHHHH | 34.01 | 20860994 | |
174 | 2-Hydroxyisobutyrylation | RLTRNVTKDHIMEIF HHCCCCCHHHHHHHH | 42.92 | - | |
174 | Acetylation | RLTRNVTKDHIMEIF HHCCCCCHHHHHHHH | 42.92 | 26051181 | |
180 (in isoform 2) | Ubiquitination | - | 1.50 | 21890473 | |
182 | Phosphorylation | DHIMEIFSTYGKIKM HHHHHHHHHCCCEEE | 26.78 | 20068231 | |
183 | Phosphorylation | HIMEIFSTYGKIKMI HHHHHHHHCCCEEEE | 26.08 | 21406692 | |
184 | Phosphorylation | IMEIFSTYGKIKMID HHHHHHHCCCEEEEE | 18.41 | 21406692 | |
186 | Acetylation | EIFSTYGKIKMIDMP HHHHHCCCEEEEECC | 28.83 | 25953088 | |
186 | Ubiquitination | EIFSTYGKIKMIDMP HHHHHCCCEEEEECC | 28.83 | - | |
188 | 2-Hydroxyisobutyrylation | FSTYGKIKMIDMPVE HHHCCCEEEEECCHH | 33.03 | - | |
188 | Ubiquitination | FSTYGKIKMIDMPVE HHHCCCEEEEECCHH | 33.03 | - | |
195 | Acetylation | KMIDMPVERMHPHLS EEEECCHHHCCCCCC | 38.11 | 19608861 | |
196 | Methylation | MIDMPVERMHPHLSK EEECCHHHCCCCCCC | 29.01 | 116279419 | |
202 | Phosphorylation | ERMHPHLSKGYAYVE HHCCCCCCCCEEEEE | 22.47 | 28851738 | |
203 | Acetylation | RMHPHLSKGYAYVEF HCCCCCCCCEEEEEE | 63.40 | 26051181 | |
203 | Ubiquitination | RMHPHLSKGYAYVEF HCCCCCCCCEEEEEE | 63.40 | 21890473 | |
203 (in isoform 1) | Ubiquitination | - | 63.40 | 21890473 | |
205 | Phosphorylation | HPHLSKGYAYVEFEN CCCCCCCEEEEEECC | 9.86 | 21082442 | |
207 | Phosphorylation | HLSKGYAYVEFENPD CCCCCEEEEEECCHH | 7.63 | 28152594 | |
218 | Acetylation | ENPDEAEKALKHMDG CCHHHHHHHHHHCCC | 67.10 | 19608861 | |
218 | Malonylation | ENPDEAEKALKHMDG CCHHHHHHHHHHCCC | 67.10 | 32601280 | |
218 | Ubiquitination | ENPDEAEKALKHMDG CCHHHHHHHHHHCCC | 67.10 | 19608861 | |
234 | Phosphorylation | QIDGQEITATAVLAP CCCCEEEEEEEEECC | 19.73 | - | |
236 | Phosphorylation | DGQEITATAVLAPWP CCEEEEEEEEECCCC | 14.51 | - | |
251 | Phosphorylation | RPPPRRFSPPRRMLP CCCCCCCCCCHHCCC | 31.98 | 22167270 | |
266 | Phosphorylation | PPPMWRRSPPRMRRR CCCHHHCCCHHHHHC | 30.59 | 22617229 | |
274 | Phosphorylation | PPRMRRRSRSPRRRS CHHHHHCCCCCCCCC | 34.99 | 26657352 | |
276 | Phosphorylation | RMRRRSRSPRRRSPV HHHHCCCCCCCCCCC | 24.81 | 30576142 | |
281 | Phosphorylation | SRSPRRRSPVRRRSR CCCCCCCCCCHHHCC | 26.40 | 20068231 | |
287 | Phosphorylation | RSPVRRRSRSPGRRR CCCCHHHCCCCCCCC | 34.99 | 30576142 | |
289 | Phosphorylation | PVRRRSRSPGRRRHR CCHHHCCCCCCCCCC | 32.71 | 30576142 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
53 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
53 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RNPS1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-218, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-155 AND SER-157, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-251; SER-266;SER-287 AND SER-289, AND MASS SPECTROMETRY. | |
"Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2phosphorylation."; Trembley J.H., Tatsumi S., Sakashita E., Loyer P., Slaughter C.A.,Suzuki H., Endo H., Kidd V.J., Mayeda A.; Mol. Cell. Biol. 25:1446-1457(2005). Cited for: FUNCTION IN PRE-MRNA SPLICING, ASSOCIATION WITH THE ACTIVESPLICEOSOME, PHOSPHORYLATION, PHOSPHORYLATION AT SER-53, MASSSPECTROMETRY, INTERACTION WITH CSNK2A1, MUTAGENESIS OF SER-53, ANDSUBCELLULAR LOCATION. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-155 ANDSER-157, AND MASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-205, AND MASSSPECTROMETRY. |